Concepedia

David B. Darr

DB

37

Publications

4.7K

Citations

30

H-Index

2011

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

Duke University

North Carolina State University

Dana-Farber Cancer Institute

David B. Darr is an author at University of North Carolina at Chapel Hill specializing in medicine, tumor biology, and breast cancer.

ORCID

Top concepts

Publications per year

2011–2021

37

Publications

37

Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer

John S. Duncan, Martin C. Whittle, Kazuhiro Nakamura et al. · Cell · 2012 · 732 citations · Full text

, , +11

Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model

Christin E. Burd, Jessica A. Sorrentino, Kelly S. Clark et al. · Cell · 2013 · 403 citations · Full text

, , +7

Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

Ronald L. Chandler, Jeffrey S. Damrauer, Jesse R. Raab et al. · Nature Communications · 2015 · 314 citations · Full text

Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy

Patrick J. Roberts, John Bisi, Jay C. Strum et al. · JNCI Journal of the National Cancer Institute · 2012 · 249 citations · Full text

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins et al. · JCI Insight · 2018 · 244 citations · Full text

Rows per page

1–5 of 37